Daxor Corporation Receives Signed Agreement from University Hospitals of Cleveland.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- Daxor Corporation, (AMEX AMEX See: American Stock Exchange : DXR DXR Danbury Municipal Airport, Danbury CT (airport code) DXR Data Extraction and Recording DXR X-Director DXR Dynamic Extended Resolution ), a medical instrumentation and biotechnology company, today announced the receipt of a signed agreement from University Hospitals of Cleveland University Hospitals is a major not-for-profit medical center in Cleveland, Ohio, United States. With 150 locations throughout northeast Ohio, it encompasses a network of hospitals, outpatient centers and primary care physicians. to obtain a Daxor BVA-100 blood volume analyzer on a trial basis. The hospital is part of the University Hospitals Health System in Ohio, which delivers care to more than 150 locations in northern Ohio. The hospital is a 947 bed tertiary medical center and is affiliated with Case Western Reserve University. The facility is noted for its pioneering work in organ transplantation services. The hospital plans to initially use the blood volume analyzer in conjunction with organ transplantation services and other appropriate areas in the hospital. The Chairman of the department is Dr. James H. Shulak. The hospital will be the second hospital in the United States to use the BVA-100 Blood Volume Analyzer in conjunction with organ transplantation. Dr. Joseph Feldschuh, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Daxor, noted that blood volume stabilization is a prime consideration in dealing with organ transplantation. Patients frequently experience a significant amount of blood loss. Physicians managing the surgery and post operative care of these patients are faced with a difficult dilemma in determining the optimum amount of fluids and blood to administer. The BVA-100 Blood Volume Analyzer provides a tool that enables physicians to treat such patients with a significantly improved degree of precision, based on direct measurements instead of indirect estimates. Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with a single use diagnostic kit. It is the first FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approved instrument to provide rapid, direct measurement of a patient's blood volume with a high degree of precision. Among nationally renowned hospitals which have purchased the BVA-100 Blood Volume Analyzer after using it on a trial basis are The Mayo Clinic, The Cleveland Clinic and New York University New York University, mainly in New York City; coeducational; chartered 1831, opened 1832 as the Univ. of the City of New York, renamed 1896. It comprises 13 schools and colleges, maintaining 4 main centers (including the Medical Center) in the city, as well as the Medical Center. The BVA-100 measures blood volume to within a 98% accuracy. More information about the BVA-100 and other Daxor products and services can be found at www.daxor.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion